Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Achromatopsia: Genetics and Gene Therapy
by
Michalakis, Stylianos
, Priglinger, Siegfried
, Priglinger, Claudia
, Rudolph, Günther
, Gerhardt, Maximilian
in
Acuity
/ Amino acids
/ Animal models
/ Biomedical and Life Sciences
/ Biomedicine
/ Blindness
/ Cancer Research
/ Children
/ Color blindness
/ Color vision
/ Cones
/ Degeneration
/ Eye movements
/ Gene therapy
/ Genes
/ Genetics
/ Human Genetics
/ Intolerance
/ Laboratory Medicine
/ Molecular Medicine
/ Morphology
/ Mutation
/ Nucleotides
/ Nystagmus
/ Pharmacotherapy
/ Photoreception
/ Photoreceptors
/ Proteins
/ Retina
/ Retinal degeneration
/ Review
/ Review Article
/ Signal transduction
/ Visual acuity
/ Visual discrimination
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Achromatopsia: Genetics and Gene Therapy
by
Michalakis, Stylianos
, Priglinger, Siegfried
, Priglinger, Claudia
, Rudolph, Günther
, Gerhardt, Maximilian
in
Acuity
/ Amino acids
/ Animal models
/ Biomedical and Life Sciences
/ Biomedicine
/ Blindness
/ Cancer Research
/ Children
/ Color blindness
/ Color vision
/ Cones
/ Degeneration
/ Eye movements
/ Gene therapy
/ Genes
/ Genetics
/ Human Genetics
/ Intolerance
/ Laboratory Medicine
/ Molecular Medicine
/ Morphology
/ Mutation
/ Nucleotides
/ Nystagmus
/ Pharmacotherapy
/ Photoreception
/ Photoreceptors
/ Proteins
/ Retina
/ Retinal degeneration
/ Review
/ Review Article
/ Signal transduction
/ Visual acuity
/ Visual discrimination
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Achromatopsia: Genetics and Gene Therapy
by
Michalakis, Stylianos
, Priglinger, Siegfried
, Priglinger, Claudia
, Rudolph, Günther
, Gerhardt, Maximilian
in
Acuity
/ Amino acids
/ Animal models
/ Biomedical and Life Sciences
/ Biomedicine
/ Blindness
/ Cancer Research
/ Children
/ Color blindness
/ Color vision
/ Cones
/ Degeneration
/ Eye movements
/ Gene therapy
/ Genes
/ Genetics
/ Human Genetics
/ Intolerance
/ Laboratory Medicine
/ Molecular Medicine
/ Morphology
/ Mutation
/ Nucleotides
/ Nystagmus
/ Pharmacotherapy
/ Photoreception
/ Photoreceptors
/ Proteins
/ Retina
/ Retinal degeneration
/ Review
/ Review Article
/ Signal transduction
/ Visual acuity
/ Visual discrimination
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Achromatopsia: Genetics and Gene Therapy
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Achromatopsia (ACHM), also known as rod monochromatism or total color blindness, is an autosomal recessively inherited retinal disorder that affects the cones of the retina, the type of photoreceptors responsible for high-acuity daylight vision. ACHM is caused by pathogenic variants in one of six cone photoreceptor-expressed genes. These mutations result in a functional loss and a slow progressive degeneration of cone photoreceptors. The loss of cone photoreceptor function manifests at birth or early in childhood and results in decreased visual acuity, lack of color discrimination, abnormal intolerance to light (photophobia), and rapid involuntary eye movement (nystagmus). Up to 90% of patients with ACHM carry mutations in
CNGA3
or
CNGB3
, which are the genes encoding the alpha and beta subunits of the cone cyclic nucleotide-gated (CNG) channel, respectively. No authorized therapy for ACHM exists, but research activities have intensified over the past decade and have led to several preclinical gene therapy studies that have shown functional and morphological improvements in animal models of ACHM. These encouraging preclinical data helped advance multiple gene therapy programs for
CNGA3
- and
CNGB3
-linked ACHM into the clinical phase. Here, we provide an overview of the genetic and molecular basis of ACHM, summarize the gene therapy-related research activities, and provide an outlook for their clinical application.
This website uses cookies to ensure you get the best experience on our website.